维普中文期刊产品整合服务
200篇 您的检索式:作者名="ARMSTRONG DK"
    题名 作者 年代 出处 被引量
1Phase Ⅱ trial of cetuximab and carboplatin in relapsed platinumsensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study显示文摘Secord AA Blessing JA Armstrong DK 2008Gynecol Oncol2008,108,3:1
2Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era : a meta-analysis 显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oneol2002,20,5:1
3Survival effect of maximal cytoreduction surgery for advanced ovarian carcinoma during the platinum era:a meta -analysis显示文摘Bristow P Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,5:1
4Recent progress in the diagno- sis and treatment of ovarian cancer显示文摘Jelovac D Armstrong DK 2011CA Cancer J Clin2011,61,3:1
5Relapsed o;arian cancer: Challenges and management strategies for a chronic disease 显示文摘Armstrong DK 2002Oncologist2002,7,5:1
6A novel insertional mutation in loricfin in Vohwinkel's Keratoderma 显示文摘Armstrong DK McKenna KE Hughes AE 1998J Invest Dermatol1998,111,4:1
7Survival effect of maximal eytoreduetive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,5:1
8Survival effect of maximal eytoreduetive surgery for advanced ovarian carcinoma during the platinum era : a meta-analysis 显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oneol2002,20,5:1
9Survivaleffect of maximal cytoreductive surgery for advanced o-varian carcinoma during the platinum era:a meta-analy-sis显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,5:1
10Recent progress in the diagnosis and treatment of ovarian cancer显示文摘Jelovac D Armstrong DK 2011CA Cancer J Clin2011,61,3:1
11Phase II trial of cetux-imab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression:a Gy-necologic Oncology Group study显示文摘Secord AA Blessing JA Armstrong DK 2008Gynecol Oncol2008,108,3:1
12Intraperitoneal cisplatin and paclitaxel in ovarian cancer显示文摘Armstrong DK Bundy B Wenzel L 2006N Engl J Med2006,354,:1
13Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta analysis 显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,5:1
14Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:a meta-analysis显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,:1
15Survival effect of maximal eytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,5:1
16Intraperitoneal cisplatin and paclitaxel in ovarian cancer显示文摘Armstrong DK Bundy B Wenzel L 0,,:1
17Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:ameta-analysis显示文摘Bristow RE Tomacruz RS Armstrong DK 0,,:1
18A phase Ⅱ trial of topotecan as salvage therapy in epithelial ovarian cancer 显示文摘Armstrong DK Rowinsky EK Donehower R 1995Proc Am Soc Clin Oncol1995,14,:1
19Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:a meta-analysis显示文摘Bristow RE Tomacruz RS Armstrong DK 2002J Clin Oncol2002,20,5:1
20Intraperitoneal cisplatin and paclitaxel in ovarian cancer显示文摘Armstrong DK Bundy B Wenzel L Huang HQ Baergen R Lele S Copeland LJ Walker JL Burger RA Gynecologic Oncology Group 2006NEngl J Med2006,354,1:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费